Clinical Trials in Seongnam, South Korea
Locations / Seongnam, South Korea
Delta Trials hosts 645 clinical trials conducted in Seongnam, South Korea, making it a notable site of clinical research activity. These trials covering 662 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 53 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Seongnam.
645
Total Trials
662
Conditions
53
Terminated since 2020
Browse by condition (662 total)
- Coronary artery disease 26 trialsAll Coronary artery disease trials
- Non-small cell lung cancer 23 trialsAll Non-small cell lung cancer trials
- Gastric cancer 22 trialsAll Gastric cancer trials
- Atrial fibrillation 13 trialsAll Atrial fibrillation trials
- Carcinoma, non-small-cell lung 11 trialsAll Carcinoma, non-small-cell lung trials
- Breast cancer 11 trialsAll Breast cancer trials
- Obesity 10 trialsAll Obesity trials
- Stroke 10 trialsAll Stroke trials
- Acute coronary syndrome 9 trialsAll Acute coronary syndrome trials
- Diabetes 9 trialsAll Diabetes trials
- Cardiovascular diseases 9 trialsAll Cardiovascular diseases trials
- Hypertension 8 trialsAll Hypertension trials
- Non-small cell lung cancer (nsclc) 8 trialsAll Non-small cell lung cancer (nsclc) trials
- Schizophrenia 8 trialsAll Schizophrenia trials
- Alzheimer's disease 8 trialsAll Alzheimer's disease trials
- Diabetes mellitus, type 2 8 trialsAll Diabetes mellitus, type 2 trials
- Hepatocellular carcinoma 7 trialsAll Hepatocellular carcinoma trials
- Prostate cancer 7 trialsAll Prostate cancer trials
- Idiopathic pulmonary fibrosis 7 trialsAll Idiopathic pulmonary fibrosis trials
- Pancreatic cancer 7 trialsAll Pancreatic cancer trials